The next round of the Biomedical Catalyst will launch on 7th June. £18 Million is available to support industry-led research and development projects that seek to provide solutions to Health and Care challenges.
The Biomedical Catalyst funding programme supports UK businesses to test and develop innovative technologies for health and care. The programme provides funding to help UK SMEs speed up the process of bringing new products to market and secure onward investment.
The Biomedical Catalyst was established in 2012 with the aim of delivering growth to the UK life sciences sector, delivering innovative life sciences products and services into healthcare more quickly and effectively, and providing support for research and development.
Support is available for any life science sector or discipline, including medical technologies and devices, advanced therapies (cell and gene therapies), digital health, drug discovery, and diagnostics.
The next competition is for Early & Late strands of the Biomedical Catalyst and will open on Monday 7th June 2021 and will close for submissions on Thursday 26th August 2021 at 11:00am.
Dr Gordon Ford
Innovation Lead – Biomedical Enabling Technologies
Health & Life Sciences